Join
Live feed
·
INSIDERFilingvia Quantisnow
Caribou Biosciences Inc. logo

President and CEO Haurwitz Rachel E. was granted 136,750 shares, increasing direct ownership by 86% to 295,450 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRBU· Caribou Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRBU (Caribou Biosciences Inc.) and more on Quantisnow.